Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAN007 in atopic dermatitis
NCT02871479Phase 2Completed
- Sponsor
- Santalis Pharmaceuticals, Inc.
- Start
- Apr 2017
- Primary completion
- Aug 2018
- Modality
- Transdermal Patches, Hydrogel Systems, Classical Binding Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of east indian sandalwood oil cream in atopic dermatitis (AD) (3 arms), sponsored by Santalis Pharmaceuticals, Inc. Primary endpoint: Number of Patients With Adverse Events at 28 days. Started Apr 2017; status: completed.
02
Drugs
east indian sandalwood oil cream
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT02871479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02871479.